- History of AACE CME Program
- CME Mission Statement
- ASAP - ACE Self Assesment Program in Endocrinology and Metabolism
- Online Enduring Materials
- SGLT2 Inhibition: A New Kidney-Based Strategy to Reduce Hyperglycemia
- Obesity and Type 2 Diabetes: Examining a Causal Relationship
- Severe Insulin Resistance in Type 2 Diabetes: Causes, Challenges, and Therapeutic Options
- Rational Use of Bariatric Surgery: The Referring Physician's Critical Role in Decision-Making
- Recent Clinical Data on the Use of GLP-1 Analogs in Type 2 Diabetes: What Have We Learned?
- Cardiometabolic Disease and CV Risk Reduction: Emerging Science and Therapeutic Options in Obesity and Type 2 Diabetes
- Improving Glycemic Control with Insulin
- Glycemic Control for the Kidney, by the Kidney: Exploring the Role of SGLT-2 Inhibition in Type 2 Diabetes Mellitus
- Managing FPG and PPG with Incretin-Based Therapies: A Therapeutic Double Play
- Primary and Secondary (GH Deficiency) Insulin Growth Factor Deficiencies: Evaluation and Management of Short Stature and Growth Disorders
- A Mandate for Early Intensive Treatment of Abdominal Obesity and Cardiometabolic Risk: Why Weight?
- American College of Endocrinology Self-Assessment Program (ASAP)
- Current Strategies and Needs for Managing the Critically Ill Patient with Diabetes
